ANTX NASDAQ
AN2 Therapeutics, Inc.
1W: +8.4%
1M: -22.9%
3M: -23.1%
YTD: +247.8%
1Y: +229.9%
3Y: -74.2%
$3.86
+0.23 (+6.34%)
Pre-Market: $4.08 (+0.23, +5.83%)
Weekly Expected Move ±11.9%
$3
$3
$4
$4
$4
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 6.39.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Oct Typical
⛈️
Stormy
-16.7% YTD avg
2026 Now
☀️
Sunny
Above typical
20yr Avg YTD
-16.7%
Day 206 of 252
2026 YTD
+247.8%
Above 20yr avg
Typical Vol
67%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+4.3%
Midterm
🌧️
-2.7%
25% win
74% vol
Feb
20yr
⛈️
-29.8%
Midterm
⛈️
-27.1%
0% win
152% vol
Mar
20yr
💨
-30.4%
Midterm
⛈️
-43.0%
60% win
201% vol
Apr
20yr
⛈️
-46.0%
Midterm
⛈️
-49.9%
40% win
71% vol
May
20yr
⛈️
-35.2%
Midterm
☀️
+8.2%
0% win
115% vol
Jun
20yr
💨
-38.8%
Midterm
⛈️
-27.3%
80% win
93% vol
Jul
20yr
💨
-30.2%
Midterm
☀️
+6.6%
60% win
71% vol
Aug
20yr
💨
-17.6%
Midterm
⛈️
-23.7%
80% win
159% vol
Sep
20yr
💨
-20.7%
Midterm
⛈️
-39.9%
60% win
107% vol
Oct
20yr
⛈️
-19.2%
Midterm
⛈️
-17.0%
20% win
67% vol
Now:
-27.4%
Nov
20yr
💨
-12.0%
Midterm
⛈️
-30.9%
50% win
91% vol
Dec
20yr
🌫️
-0.1%
Midterm
⛈️
-4.4%
50% win
60% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +247.8%